Table 3.
Clinical features and outcomes of the patients who underwent surgery
| Variables | ROLL-MIP (n=19) | Exploration Surgery (n=2) | p |
|---|---|---|---|
| ASA score, n (%) | 0.567 | ||
| 1 | 5 (26.3) | 1 (50.0) | |
| 2 | 13 (68.4) | 1 (50.0) | |
| 3 | 1 (5.3) | 0 (0.0) | |
| LOS (minute), Median (IQR) | 35.0 (30.0-45.0) | 110.0 (70.0-na) | 0.010 |
| Lesion volume (mm3), Median (IQR) | 251.2 (78.5-690.8) | 543.0 (497.0-na) | 0.343 |
| Histopathologic diagnosis, n (%) | 0.567 | ||
| Adenoma | 13 (68.4) | 1 (50.0) | |
| Hyperplasia | 3 (15.8) | 1 (50.0) | |
| Concurrent adenoma and hyperplasia | 3 (15.8) | 0 (0.0) | |
| Surgical success, n (%) | 19 (100.0) | 2 (100.0) | na |
| Complication, n (%) | 3 (15.8) | 1 (50.0) | 0.352 |
Note: ROLL-MIP: Radio-guided occult lesion localization-minimally invasive parathyroidectomy, ASA: American Society of Anesthesiology, LOS: Length of surgery, na: Not applicable.